Caring for patients with rare diseases during the COVID-19 pandemic

Rare diseases frequently attack and weaken the immune system, increasing the patient’s vulnerability to develop severe conditions after viral infections, such as COVID-19. Many patients with rare diseases also suffer from mental retardation and disability. These rare disease phenotypes do not emerg...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohamed Boudjelal, Nimer Mehyar, Bandar Alghanem, Faisal Almajed, Majid Alfadhel
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2021-04-01
Series:Journal of Infection in Developing Countries
Subjects:
Online Access:https://jidc.org/index.php/journal/article/view/13214
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Rare diseases frequently attack and weaken the immune system, increasing the patient’s vulnerability to develop severe conditions after viral infections, such as COVID-19. Many patients with rare diseases also suffer from mental retardation and disability. These rare disease phenotypes do not emerge in older people who are susceptible to COVID-19 infection, but present at a very young age or at birth. These factors must be taken in consideration when caring for this vulnerable patient population during a pandemic, such as COVID-19. Patients with a rare disease have to take their regular medication continuously to control their condition and frequently, the medications, directly or indirectly, affect their immune system. It is important for this patient population, if infected with COVID-19 or another severe form of infection, to adjust the treatment protocol by specialists, in consultation with their own medical team. Special awareness and educational programs, understandable for mentally retarded patients, must be developed to educate them about social distancing, curfew, sanitization, and sensitization to the disease and quarantine. The COVID-19 pandemic highlighted the importance to reconsider the care required by patients with a rare disease during a pandemic or disaster, a program that should be adopted by the World Health Organization and governmental institutions for consideration.
ISSN:1972-2680